LV
LBBW Venture Capital
Stuttgart, GermanyFounded 1998
LBBW Venture Capital focuses on early-stage disruptive IT and life science companies within the DACH region, typically investing in Seed to Series A or B funding rounds. Their strategy targets startups in Digital Transformation (including Enterprise IT, IoT, Industry 4.0, AI/ML, Big Data & Analytics), Life Science and HealthTech (drug development, diagnostics, MedTech, and Healthcare IT), and Financial Technology.
67% of their portfolio is in Enterprise Software. Their most common stage is series-b (67% of deals). Average disclosed round size is $43.3M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Exciva | Series B | $59M | Jan 2026 |
| EExciva GmbH | Series B | $59M | Jan 2025 |
 Code Intelligence | Series A | $12M | Jun 2022 |
Top Co-Investors
Gimv2 shared
EQT Life Sciences2 shared
Fountain Healthcare2 shared
LifeArc Ventures2 shared
Carma Fund2 shared
Andera Partners2 shared
Verve Ventures1 shared
HTGF1 shared
GitHub1 shared
Last updated: 16 April 2026